Mapi Continues Organic Growth and Expansion in the United Kingdom

Building on Mapi's quarter of a century of innovation and leadership in the UK, the expansion into Imperial's recently completed Translation & Innovation Hub  (I-HUB) offers a modern and inspiring workspace. The prominent location and compelling work environment will help to foster new ideas in a collaborative environment that enables Mapi to continue attracting top talent in the region.  "Our new White City Global Leadership Centre enables management and operational leaders to access the knowledge and dynamism in the UK's golden triangle of leading universities and entrepreneurs," commented Mapi's CEO, James Karis.  "The chance to be part of this research ecosystem and the scientific community that calls London home was a key factor in our decision to locate at the I-HUB."

"This London expansion is a key step in Mapi's continued growth strategy," expanded Dr William Maier, Mapi's Chief Scientfic Officer and Head of Mapi's Patient-Centered Sciences group. "The abundance of patient-focused medical research in London and the comprehensive care provided by the UK National Health Service make this the ideal environment to find new ways of improving individual engagement with personal health while controlling health care costs. "

Dr Eulian Roberts, Chief Executive of Imperial College London ThinkSpace, which operates the I-HUB, said: "Mapi is a fantastic addition to the I-HUB.  It is committed to putting the patient at the heart of healthcare research and driving improvements in the way that medical treatment is delivered and experienced. Mapi joins a thriving enterprising environment at White City where the sharing of ideas and research will help us to reach new heights not just in medicine, but also in engineering, science and business.  Bringing together some of the world's greatest minds in one place, we'll be able to leverage their collective knowledge and tackle some of the biggest challenges facing us today."

About Mapi: Patients are at the heart of our research

Mapi Group has over 40 years of experience supporting Life-Science companies as the world leading Patient-Centered Research company in commercializing novel treatments through Real-World Evidence, Strategic Regulatory Services, Pharmacovigilance,  Market Access, Language Services. Mapi Group is the premier provider of Health Research and Commercialization services to Life-Science companies enabling Market Authorization, Market Access and Market Adoption of novel therapeutics by leveraging Patient Sciences such as Patient Insights and Engament, Patient-Centered Outcoms and Patient Logistics as the foundational elements to all our services and solutions.  Visit http://www.mapigroup.com for more information

Press contact: [email protected]

SOURCE Mapi